Hospital Universitario Virgen Macarena   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Seville Spain (1974)

Organization Overview

First Clinical Trial
2008
NCT00781404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hospital Universitario Viren MAcarena. Sevilla | Hospital Universitario Virgen Macarena | Hospital Universitario Virgen Macarena, Sevilla, Spain | Virgen Macarena Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 3)

Asthma (Phase 4)

Bacteremia (Phase 3)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Fibrosis (Phase 3)

Hepatitis (Phase 3)

Hepatitis C (Phase 3)

HIV Infections (Phase 3)

Infarction (Phase 3)

Infections (Phase 3)

Liver Cirrhosis (Phase 3)

Lung Diseases, Obstructive (Phase 4)

Lung Neoplasms (Phase 2)

Meningitis (Phase 4)

Meningitis, Pneumococcal (Phase 4)

Myocardial Infarction (Phase 3)

Osteoarthritis, Hip (Phase 3)

Pseudomonas Infections (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Seizures (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 18